525 related articles for article (PubMed ID: 22971222)
21. Curcumin: a boon to colonic diseases.
Sareen R; Jain N; Pandit V
Curr Drug Targets; 2013 Sep; 14(10):1210-8. PubMed ID: 23768171
[TBL] [Abstract][Full Text] [Related]
22. Advances in curcumin-loaded nanopreparations: improving bioavailability and overcoming inherent drawbacks.
Zhang Y; Rauf Khan A; Fu M; Zhai Y; Ji J; Bobrovskaya L; Zhai G
J Drug Target; 2019 Nov; 27(9):917-931. PubMed ID: 30672353
[TBL] [Abstract][Full Text] [Related]
23. Liposomal curcumin and its application in cancer.
Feng T; Wei Y; Lee RJ; Zhao L
Int J Nanomedicine; 2017; 12():6027-6044. PubMed ID: 28860764
[TBL] [Abstract][Full Text] [Related]
24. Recent updates in curcumin delivery.
Obeid MA; Alsaadi M; Aljabali AA
J Liposome Res; 2023 Mar; 33(1):53-64. PubMed ID: 35699160
[TBL] [Abstract][Full Text] [Related]
25. Is curcumin bioavailability a problem in humans: lessons from clinical trials.
Kunnumakkara AB; Harsha C; Banik K; Vikkurthi R; Sailo BL; Bordoloi D; Gupta SC; Aggarwal BB
Expert Opin Drug Metab Toxicol; 2019 Sep; 15(9):705-733. PubMed ID: 31361978
[No Abstract] [Full Text] [Related]
26. Carbon-based Nanomaterials and Curcumin: A Review of Biosensing Applications.
Mohajeri M; Behnam B; Tasbandi A; Jamialahmadi T; Sahebkar A
Adv Exp Med Biol; 2021; 1291():55-74. PubMed ID: 34331684
[TBL] [Abstract][Full Text] [Related]
27. Trends in advanced oral drug delivery system for curcumin: A systematic review.
Pan-On S; Dilokthornsakul P; Tiyaboonchai W
J Control Release; 2022 Aug; 348():335-345. PubMed ID: 35654170
[TBL] [Abstract][Full Text] [Related]
28. Biomedical Applications and Bioavailability of Curcumin-An Updated Overview.
Sohn SI; Priya A; Balasubramaniam B; Muthuramalingam P; Sivasankar C; Selvaraj A; Valliammai A; Jothi R; Pandian S
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959384
[TBL] [Abstract][Full Text] [Related]
29. Exploring the use of nanocarrier systems to deliver the magical molecule; Curcumin and its derivatives.
Mehanny M; Hathout RM; Geneidi AS; Mansour S
J Control Release; 2016 Mar; 225():1-30. PubMed ID: 26778694
[TBL] [Abstract][Full Text] [Related]
30. Hansen solubility parameters (HSP) for prescreening formulation of solid lipid nanoparticles (SLN): in vitro testing of curcumin-loaded SLN in MCF-7 and BT-474 cell lines.
Doktorovova S; Souto EB; Silva AM
Pharm Dev Technol; 2018 Jan; 23(1):96-105. PubMed ID: 28949267
[TBL] [Abstract][Full Text] [Related]
31. Novel curcumin oral delivery systems.
Kurita T; Makino Y
Anticancer Res; 2013 Jul; 33(7):2807-21. PubMed ID: 23780965
[TBL] [Abstract][Full Text] [Related]
32. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.
Ahmad MZ; Alkahtani SA; Akhter S; Ahmad FJ; Ahmad J; Akhtar MS; Mohsin N; Abdel-Wahab BA
J Drug Target; 2016; 24(4):273-93. PubMed ID: 26066739
[TBL] [Abstract][Full Text] [Related]
33. The bioavailability, metabolism and microbial modulation of curcumin-loaded nanodelivery systems.
Chang R; Chen L; Qamar M; Wen Y; Li L; Zhang J; Li X; Assadpour E; Esatbeyoglu T; Kharazmi MS; Li Y; Jafari SM
Adv Colloid Interface Sci; 2023 Aug; 318():102933. PubMed ID: 37301064
[TBL] [Abstract][Full Text] [Related]
34. Curcumin and genistein coloaded nanostructured lipid carriers: in vitro digestion and antiprostate cancer activity.
Aditya NP; Shim M; Lee I; Lee Y; Im MH; Ko S
J Agric Food Chem; 2013 Feb; 61(8):1878-83. PubMed ID: 23362941
[TBL] [Abstract][Full Text] [Related]
35. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies.
Mirzaei H; Shakeri A; Rashidi B; Jalili A; Banikazemi Z; Sahebkar A
Biomed Pharmacother; 2017 Jan; 85():102-112. PubMed ID: 27930973
[TBL] [Abstract][Full Text] [Related]
36. A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin.
Shukla M; Jaiswal S; Sharma A; Srivastava PK; Arya A; Dwivedi AK; Lal J
Drug Dev Ind Pharm; 2017 May; 43(5):847-861. PubMed ID: 27648633
[TBL] [Abstract][Full Text] [Related]
37. Developmental Strategies of Curcumin Solid Dispersions for Enhancing Bioavailability.
Tran PHL; Tran TTD
Anticancer Agents Med Chem; 2020; 20(16):1874-1882. PubMed ID: 32640962
[TBL] [Abstract][Full Text] [Related]
38. Molecular complexation of curcumin with pH sensitive cationic copolymer enhances the aqueous solubility, stability and bioavailability of curcumin.
Kumar S; Kesharwani SS; Mathur H; Tyagi M; Bhat GJ; Tummala H
Eur J Pharm Sci; 2016 Jan; 82():86-96. PubMed ID: 26588875
[TBL] [Abstract][Full Text] [Related]
39. Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications.
Chen Y; Lu Y; Lee RJ; Xiang G
Int J Nanomedicine; 2020; 15():3099-3120. PubMed ID: 32431504
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Applications of Curcumin Nanoformulations.
Yallapu MM; Nagesh PK; Jaggi M; Chauhan SC
AAPS J; 2015 Nov; 17(6):1341-56. PubMed ID: 26335307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
